Search
Genetic Variant Linked to Nerve-related Side Effects from Childhood ALL Treatment
- OPACC
- Feb 24, 2015
- 1 min read
A genome-wide association study published today in the Journal of the American Medical Association describes a regulatory variant that appears to dial up the risk of adverse outcomes in children with acute lymphoblastic leukemia who are treated with the anti-cancer drug vincristine.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...